Performance of FISH for the Diagnosis of Malignant Biliary Strictures in Thai Patients

NCT02442167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2023-12-14

No results posted yet for this study

Summary

Fluorescence in situ hybridization (FISH) has improved the diagnostic performance of cytology for evaluation of malignant biliary strictures in the US and Europe. The utility of FISH for diagnosis of biliary strictures in Asia is currently unknown. The investigators conducted a prospective study in 2 university hospitals to determine diagnostic performance of FISH for the diagnosis of malignant biliary strictures in Thai patients.

Conditions

  • Bile Duct Stricture
  • Malignancy

Sponsors & Collaborators

  • Chulalongkorn University

    collaborator OTHER
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Lewis R Roberts, MB, ChB, PhD · Mayo Clinic, Rochester, MN, USA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-12-31
Completion
2014-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02442167 on ClinicalTrials.gov